Speaker illustration

Miss Joana Neiva

Hospital de Vila Franca de Xira, Vila Franca de Xira (Portugal)

Is there a role to implantable cardioverter defibrillator for primary prevention in non-ischemic dilated cardiomiopathy?

Event: ESC Congress 2018

Topic: Cardioversion and Defibrillation

Session: Implantable cardioverter defibrillation : treatment outcomes

Thumbnail

Tolerability and safety of sacubitril/valsartan in high-risk subgroups

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Thumbnail

Effectiveness of Sacubitril/Valsartan in real-life practice: experience of a single center

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Is there a role to implantable cardioverter defibrillator for primary prevention in non-ischemic dilated cardiomiopathy?

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Implantable Cardioverter / Defibrillator

Thumbnail

Tolerability and safety of Sacubitril/Valsartan in real-life practice

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Biomarkers and imaging as prognosis impact factors in pulmonary embolism.

Event: Acute Cardiovascular Care 2016

Topic: Thrombosis / embolism

Session: DVT and pulmonary embolism

Thumbnail

1 year prognosis in acute pulmonary embolism: validation of PESI and sPESI prognostic models.

Event: Acute Cardiovascular Care 2016

Topic: Thrombosis / embolism

Session: DVT and pulmonary embolism

Thumbnail

This platform is supported by

logo Novo Nordisk